IPO Guru
Nephrocare Health Services IPO Logo

Nephrocare Health Services IPO — Date, Price Band, GMP & Allotment 2025

Mainboard Closed

Nephrocare Health Services is a specialized dialysis care provider operating the NephroPlus network with more than 519 clinics across India and abroad (including Philippines, Uzbekistan, Nepal). The company delivers comprehensive renal care services such as in-clinic haemodialysis, mobile and home dialysis, wellness programmes, and pharmacy support. It serves a significant share of dialysis patients and aims to expand its clinic footprint in Indiprovider)

Open 10 Dec 2025
Close 12 Dec 2025
Allotment 15 Dec 2025
Listing 17 Dec 2025

IPO Review

100 Strong Apply 10 reviews
Check Reviews

IPO GMP

₹ 0 (--)
Check GMP

Subscription

13.96 Times
View Sub

Stock Price

As the IPO is listed, here is the Live Share Price for Nephrocare Health Services

Loading market data...

IPO Summary

IPO Dates 10 to 12 Dec, 2025
Price Band ₹438 – 460
Face Value ₹2
Lot Size 32 Shares
Issue Size ₹871.05 Cr
Employee Discount NA
Listing On BSE & NSE
Min Investment ₹ 14,720

What is the Nephrocare Health Services IPO Timetable?

Track the IPO schedule and key events.

Event Date Day
IPO Open Date 10 Dec, 2025 Wednesday
IPO Close Date 12 Dec, 2025 Friday
Basis of Allotment 15 Dec, 2025 Monday
Refunds Initiated 16 Dec, 2025 Tuesday
Credit to Demat 16 Dec, 2025 Tuesday
Listing Date 17 Dec, 2025 Wednesday

What is the Nephrocare Health Services IPO Lot Size?

Bidding in multiples of 32 shares.

Application Lots Shares Amount
Retail (Min) 1 32 ₹14,720
Retail (Max) 13 416 ₹1,91,360
S-HNI (Min) 14 448 ₹2,06,080
S-HNI (Max) 67 2144 ₹9,86,240
B-HNI (Min) 68 2176 ₹10,00,960

About Nephrocare Health Services

Nephrocare Health Services Limited is a healthcare-focused company established with the objective of providing specialised kidney care services across India. The company was founded by experienced medical professionals and healthcare entrepreneurs who identified the growing need for quality and accessible dialysis treatment. Over the years, it has expanded its presence by setting up centres in hospitals as well as standalone units, building a network that caters to patients suffering from chronic kidney diseases. With a strong focus on clinical quality and patient care, the company has developed a reputation for reliable and standardised treatment protocols.

The company primarily offers dialysis services, including haemodialysis and related renal care treatments, supported by trained medical staff and modern equipment. Its business model is asset-light and partnership-driven, where it collaborates with hospitals to operate dialysis centres within their premises, reducing capital expenditure while expanding reach. Revenue is generated through long-term service agreements and patient volumes. Promoted by professionals with domain expertise, Nephrocare focuses on operational efficiency, affordability, and scalability, aiming to address the rising demand for kidney care services in both urban and semi-urban regions.

Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.

Nephrocare Health Services Key Performance Indicators (KPIs)

Objects of the Issue

Issue Object
BRLMs fees and commissions (including underwriting commission, brokerage and selling commission)
Estimate Amount
Issue Object
Fees payable to the Registrar to the Offer
Estimate Amount
Issue Object
Selling commission/processing fee for SCSBs and Bankers to the Offer, fee payable to the Sponsor Bank for Bids made by RII using UPI, brokerage and selling commission and bidding charges for the Members of the Syndicate, Registered Brokers, RTAs and CDPs
Estimate Amount
Issue Object
Advertising and marketing expenses
Estimate Amount
Issue Object
Listing fees, SEBI filing fees, BSE and NSE processing fees, book building software fees
Estimate Amount
Issue Object
Other regulatory expenses
Estimate Amount
Issue Object
Printing and stationery expenses
Estimate Amount
Issue Object
Fees payable to the legal counsel
Estimate Amount
Issue Object
Fees payable to other advisors to the Offer, including but not limited to Statutory Auditors, independent chartered accountant, industry expert
Estimate Amount
Issue Object
Miscellaneous
Estimate Amount

Company Financials

The Nephrocare Health Services company's financial performance (in ₹ Cr.) is summarized below:

Metric 30 Mar 25 31 Mar 24 31 Mar 24
Revenue 483.97 769.92 574.72
EBITDA 110.31 166.64 99.66
Net Profit 14.23 67.10 35.13
Debt 207.04 225.80 243.37
Assets 1,193.68 996.46 806.02

See how this IPO compares — view listing performance of all mainboard IPOs.

Promoters and Shareholding Details

Promoter holding details will be updated as soon as they are officially announced.

Frequently Asked Questions

What is the GMP of Nephrocare Health Services?

The current Grey Market Premium (GMP) of Nephrocare Health Services is ₹ 0.

What is the Nephrocare Health Services IPO Price Band?

The price band for Nephrocare Health Services IPO is ₹438 to ₹460.

When is the Nephrocare Health Services IPO Allotment?

The allotment date for Nephrocare Health Services IPO is December 15, 2025.

How to check Nephrocare Health Services IPO Allotment Status?

You can check the allotment status on the IPO Allotment Status page or on the registrar's website (Kfin Technologies Ltd.).

Official Documents

Company Contact Details

Nephrocare Health Services

Nephrocare Health Services Ltd. Address 5 th Floor, D Block, iLabs Centre, Plot 18, Software Units Layout, Survey No. 64, Madhapur, Shaikpet, Hyderabad, Telangana, 500081

+91 40 4240 8039

Registrar

Kfin Technologies Ltd.

04067162222, 04079611000

Book Running Lead Manager

ICICI Securities Ltd Ambit Pvt. Ltd IIFL Capital Services Nomura Financial Advisory & Securities (India) Pvt Ltd

Discussion 0

💡
Commenting as
Markdown supported: **bold**, _italics_

No comments yet

Be the first to share your thoughts!